Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia - a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH)

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 892-900

Elsevier

Access to resources Recommend Favorite

Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia

By Mochtar C.A.   Kiemeney L.A.L.M.   van Riemsdijk M.M.   Barnett G.S.   Laguna M.P.   Debruyne F.M.J.   de la Rosette J.J.M.C.H.  

European Urology, Vol. 44, Iss. 6, 2003-12 ,pp. : 695-700

Elsevier

Access to resources Recommend Favorite

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

By Andersen J.T.   Curtis Nickel J.   Marshall V.R.   Schulman C.C.   Boyle P.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 839-845

Elsevier

Access to resources Recommend Favorite

Increased prostatic blood flow in response to microwave thermal treatment: preliminary findings in two patients with benign prostatic hyperplasia

By Larson T.R.   Collins J.M.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 584-590

Elsevier

Access to resources Recommend Favorite

Treatment of men with minimally symptomatic benign prostatic hyperplasia-PRO: the argument in favor

By Marks L.S.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 781-783

Elsevier

Access to resources Recommend Favorite